Annual Operating Expenses
$48.34 M
+$1.41 M+3.01%
31 December 2023
Summary:
Cytosorbents annual total operating expenses is currently $48.34 million, with the most recent change of +$1.41 million (+3.01%) on 31 December 2023. During the last 3 years, it has risen by +$9.57 million (+24.67%). CTSO annual operating expenses is now -6.70% below its all-time high of $51.81 million, reached on 31 December 2021.CTSO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$8.90 M
+$31.60 K+0.36%
30 September 2024
Summary:
Cytosorbents quarterly total operating expenses is currently $8.90 million, with the most recent change of +$31.60 thousand (+0.36%) on 30 September 2024. Over the past year, it has dropped by -$3.00 million (-25.21%). CTSO quarterly operating expenses is now -44.85% below its all-time high of $16.14 million, reached on 31 December 2021.CTSO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | -25.2% |
| 3 y3 years | +24.7% | -24.9% |
| 5 y5 years | +70.5% | -7.9% |
CTSO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.7% | +24.7% | -44.9% | +0.4% |
| 5 y | 5 years | -6.7% | +70.5% | -44.9% | +7.9% |
| alltime | all time | -6.7% | +1611.6% | -44.9% | +1197.0% |
Cytosorbents Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.90 M(+0.4%) |
| June 2024 | - | $8.87 M(-17.1%) |
| Mar 2024 | - | $10.70 M(-19.8%) |
| Dec 2023 | $48.34 M(+3.0%) | $13.33 M(+12.0%) |
| Sept 2023 | - | $11.90 M(+6.0%) |
| June 2023 | - | $11.23 M(-4.9%) |
| Mar 2023 | - | $11.81 M(+13.9%) |
| Dec 2022 | $46.93 M(-9.4%) | $10.36 M(-5.7%) |
| Sept 2022 | - | $10.99 M(-9.5%) |
| June 2022 | - | $12.14 M(-9.7%) |
| Mar 2022 | - | $13.44 M(-16.7%) |
| Dec 2021 | $51.81 M(+33.6%) | $16.14 M(+36.2%) |
| Sept 2021 | - | $11.84 M(-12.8%) |
| June 2021 | - | $13.58 M(+32.6%) |
| Mar 2021 | - | $10.24 M(-12.0%) |
| Dec 2020 | $38.77 M(+12.8%) | $11.64 M(+24.9%) |
| Sept 2020 | - | $9.31 M(-2.6%) |
| June 2020 | - | $9.57 M(+16.0%) |
| Mar 2020 | - | $8.25 M(-17.1%) |
| Dec 2019 | $34.38 M(+21.3%) | $9.95 M(+3.0%) |
| Sept 2019 | - | $9.66 M(+26.3%) |
| June 2019 | - | $7.65 M(+7.3%) |
| Mar 2019 | - | $7.12 M(-20.6%) |
| Dec 2018 | $28.35 M(+60.1%) | $8.97 M(+55.8%) |
| Sept 2018 | - | $5.76 M(-24.7%) |
| June 2018 | - | $7.65 M(+28.2%) |
| Mar 2018 | - | $5.97 M(-12.7%) |
| Dec 2017 | $17.71 M(+12.5%) | $6.84 M(+67.5%) |
| Sept 2017 | - | $4.08 M(+4.9%) |
| June 2017 | - | $3.89 M(+34.2%) |
| Mar 2017 | - | $2.90 M(-50.7%) |
| Dec 2016 | $15.74 M(+41.2%) | $5.89 M(+77.1%) |
| Sept 2016 | - | $3.32 M(-9.4%) |
| June 2016 | - | $3.67 M(+27.9%) |
| Mar 2016 | - | $2.87 M(-14.5%) |
| Dec 2015 | $11.15 M | $3.35 M(+29.9%) |
| Sept 2015 | - | $2.58 M(+1.4%) |
| June 2015 | - | $2.55 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $2.66 M(-22.8%) |
| Dec 2014 | $7.90 M(+118.1%) | $3.45 M(+68.8%) |
| Sept 2014 | - | $2.04 M(+49.8%) |
| June 2014 | - | $1.36 M(+28.3%) |
| Mar 2014 | - | $1.06 M(+121.1%) |
| Dec 2013 | $3.62 M(+9.0%) | $480.60 K(+3.8%) |
| Sept 2013 | - | $462.80 K(-65.3%) |
| June 2013 | - | $1.34 M(-0.7%) |
| Mar 2013 | - | $1.34 M(+59.6%) |
| Dec 2012 | $3.32 M(-25.5%) | $842.70 K(+78.2%) |
| Sept 2012 | - | $473.00 K(-54.2%) |
| June 2012 | - | $1.03 M(+0.2%) |
| Mar 2012 | - | $1.03 M(+3.8%) |
| Dec 2011 | $4.46 M(+58.0%) | $992.80 K(-19.0%) |
| Sept 2011 | - | $1.23 M(+10.0%) |
| June 2011 | - | $1.11 M(-1.3%) |
| Mar 2011 | - | $1.13 M(+181.3%) |
| Dec 2010 | $2.82 M(-6.7%) | $401.20 K(-48.6%) |
| Sept 2010 | - | $780.70 K(+15.8%) |
| June 2010 | - | $674.40 K(-30.3%) |
| Mar 2010 | - | $967.80 K(+70.4%) |
| Dec 2009 | $3.03 M(-6.7%) | $567.90 K(-32.4%) |
| Sept 2009 | - | $840.60 K(-1.5%) |
| June 2009 | - | $853.30 K(+11.5%) |
| Mar 2009 | - | $765.60 K(-16.4%) |
| Dec 2008 | $3.24 M(+5.8%) | $916.00 K(+5.3%) |
| Sept 2008 | - | $870.30 K(-207.3%) |
| June 2008 | - | -$811.30 K(-225.5%) |
| Mar 2008 | - | $646.60 K(+7.2%) |
| Dec 2007 | $3.07 M(+3.5%) | $603.20 K(-12.1%) |
| Sept 2007 | - | $686.20 K(+11.1%) |
| June 2007 | - | $617.90 K(-46.7%) |
| Mar 2007 | - | $1.16 M(+28.4%) |
| Dec 2006 | $2.96 M | $903.00 K(+35.1%) |
| Sept 2006 | - | $668.50 K(+15.0%) |
| June 2006 | - | $581.40 K(+5283.3%) |
| Feb 2006 | - | $10.80 K(-17.6%) |
| Nov 2005 | - | $13.10 K(-98.4%) |
| Aug 2005 | - | $811.30 K |
FAQ
- What is Cytosorbents annual total operating expenses?
- What is the all time high annual operating expenses for Cytosorbents?
- What is Cytosorbents annual operating expenses year-on-year change?
- What is Cytosorbents quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cytosorbents?
- What is Cytosorbents quarterly operating expenses year-on-year change?
What is Cytosorbents annual total operating expenses?
The current annual operating expenses of CTSO is $48.34 M
What is the all time high annual operating expenses for Cytosorbents?
Cytosorbents all-time high annual total operating expenses is $51.81 M
What is Cytosorbents annual operating expenses year-on-year change?
Over the past year, CTSO annual total operating expenses has changed by +$1.41 M (+3.01%)
What is Cytosorbents quarterly total operating expenses?
The current quarterly operating expenses of CTSO is $8.90 M
What is the all time high quarterly operating expenses for Cytosorbents?
Cytosorbents all-time high quarterly total operating expenses is $16.14 M
What is Cytosorbents quarterly operating expenses year-on-year change?
Over the past year, CTSO quarterly total operating expenses has changed by -$3.00 M (-25.21%)